Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News CorMedix Inc CRMD

Healthcare
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections... see more

Recent & Breaking News (NDAQ:CRMD)

CorMedix Inc. Closes $3,000,000 Preferred Stock Offerings

PR Newswire October 23, 2013

CorMedix Inc. to Raise $3,000,000 in Concurrent Offerings

PR Newswire October 18, 2013

CorMedix Reports Receipt of European Patent Office Decision to Allow Prosl Patent to Proceed in European Union

PR Newswire September 5, 2013

CorMedix Reports Second Quarter 2013 Results

PR Newswire August 14, 2013

CorMedix Granted Extension of NYSE MKT Listing

PR Newswire July 15, 2013

CorMedix Receives CE Mark for Neutrolin® Catheter Lock Solution

Business Wire July 5, 2013

CorMedix Granted Extension of NYSE MKT Listing

Business Wire May 31, 2013

CorMedix Granted Extension of NYSE MKT Listing

Business Wire April 22, 2013

CorMedix Notified of NYSE MKT Listing Deficiency

Business Wire April 11, 2013

CorMedix Reports Year End 2012 Financial Results

Business Wire March 27, 2013

CorMedix Granted Extension of NYSE MKT Listing

Business Wire February 7, 2013

CorMedix Signs Sales and Marketing Agreement with MKM Co-Pharma, Bolsters Commercial Management Team to Ready Neutrolin® Catheter Lock Solution for European Market

Business Wire January 15, 2013

CorMedix Announces Changes in Executive Team

Business Wire December 24, 2012